tradingkey.logo
tradingkey.logo
Search

Pacific Biosciences of California Inc

PACB
Add to Watchlist
1.395USD
+0.015+1.09%
Close 07-23 16:00ETQuotes delayed by 15 min
433.13MMarket Cap
LossP/E TTM

Pacific Biosciences of California Inc

1.395
+0.015+1.09%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+1.09%

5 Days

-6.38%

1 Month

+6.49%

6 Months

-45.93%

Year to Date

-25.40%

1 Year

-17.46%

Key Figures
1.360Open
1.430High
6.86MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
2.21%Turnover Ratio
1.380Prev. Close
1.360Low
7.58MTurnover
LossP/E Static
183.06P/B
0.00%Div Yield TTM
-15.65%ROA
2.73052wk High
0.92Volume Ratio
-309.85MNet Profit
310.49MShares
-0.4133EPS TTM
2.36Beta
-273.55%ROE
0.96052wk Low
5.07%Amplitude
32.30%Gross Margin
433.13MMarket Cap
-0.82Reward/Risk
5.08%Risk Rate

Key Insights

Pacific Biosciences of California Inc's fundamentals are relatively weak, and its growth potential is significant.Its valuation is considered fairly valued, ranking 108 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.46.In the medium term, the stock price is expected to trend down.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Pacific Biosciences of California Inc's Score

Industry at a Glance

Industry Ranking
108 / 200
Overall Ranking
211 / 4547
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Pacific Biosciences of California Inc Highlights

StrengthsRisks
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 160.00M.
Undervalued
The company’s latest PE is -3.39, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 192.85M shares, decreasing 9.18% quarter-over-quarter.
Held by Catherine Wood
Star Investor Catherine Wood holds 37.12M shares of this stock.

Analyst Rating

Based on 8 analysts
Buy
Current Rating
2.458
Target Price
+75.59%
Upside Space

Pacific Biosciences of California Inc News

More news coming soon, stay tuned...

Indicators

Indicators
Sell(1)
Neutral(4)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.053
Neutral
RSI(14)
44.107
Neutral
STOCH(KDJ)(9,3,3)
21.469
Neutral
ATR(14)
0.094
Low Volatility
CCI(14)
-95.582
Neutral
Williams %R
83.117
Oversold
TRIX(12,20)
-0.079
Sell
StochRSI(14)
76.997
Buy
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
1.396
Sell
MA10
1.455
Sell
MA20
1.548
Sell
MA50
1.428
Sell
MA100
1.449
Sell
MA200
1.711
Sell

Pacific Biosciences of California Inc Info

Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
Ticker SymbolPACB
CompanyPacific Biosciences of California Inc
CEOHenry (Christian O)
Websitehttps://www.pacb.com/

FAQs

What is the current price of Pacific Biosciences of California Inc (PACB)?

The current price of Pacific Biosciences of California Inc (PACB) is 1.40.

What is the symbol of Pacific Biosciences of California Inc?

The ticker symbol of Pacific Biosciences of California Inc is PACB.

What is the 52-week high of Pacific Biosciences of California Inc?

The 52-week high of Pacific Biosciences of California Inc is 2.73.

What is the 52-week low of Pacific Biosciences of California Inc?

The 52-week low of Pacific Biosciences of California Inc is 0.96.

What is the market capitalization of Pacific Biosciences of California Inc?

The market capitalization of Pacific Biosciences of California Inc is 433.13M.

Is Pacific Biosciences of California Inc (PACB) currently rated as Buy, Hold, or Sell?

According to analysts, Pacific Biosciences of California Inc (PACB) has an overall rating of Buy, with a price target of 2.46.

What is the Earnings Per Share (EPS TTM) of Pacific Biosciences of California Inc (PACB)?

The Earnings Per Share (EPS TTM) of Pacific Biosciences of California Inc (PACB) is -1.82.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.